Strategic Research Agreement — Round 2
Funds investigator-initiated type 1 diabetes projects spanning early detection, prevention, and advanced therapeutic development pipelines.
Breakthrough T1D's Strategic Research Agreement (SRA) program funds investigator-initiated research across all five of the organisation's scientific priority areas — early detection, disease-modifying therapies, cell therapies, improving lives, and growing the research community — through a cooperative partnership model that pairs academic investigators with Breakthrough T1D staff scientists. Brea…
Investigator-initiated type 1 diabetes research across all five Breakthrough T1D priority areas, structured as a cooperative milestone-based partnership with funder scientists.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline